{
    "title": "Eli Lilly to add eczema drug with $1.1 bln deal for Dermira",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7873019/Eli-Lilly-buy-skin-disease-specialist-Dermira-1-1-billion.html",
    "date": "2020-01-10",
    "keywords": [
        "dermira",
        "price",
        "drug",
        "dermatitis",
        "treatment",
        "inc",
        "atopic",
        "condition",
        "share",
        "premium",
        "closing",
        "chen",
        "acquisition",
        "lebrikizumab",
        "year",
        "cancer",
        "adviser",
        "friday",
        "disease",
        "specialist",
        "cash",
        "arsenal",
        "therapy",
        "trading",
        "month",
        "offer",
        "movement",
        "bidder",
        "cantor",
        "analyst",
        "louise",
        "pfizer",
        "skin",
        "form",
        "eczema",
        "latestage",
        "testing",
        "cloth",
        "armpit",
        "roche",
        "ag",
        "deal",
        "sa",
        "option",
        "regeneron",
        "dupixent",
        "class",
        "immunology",
        "psoriasis",
        "taltz",
        "sum",
        "loxo",
        "oncology",
        "pipeline",
        "core",
        "blockbuster",
        "humalog",
        "face",
        "pressure",
        "competition",
        "strategy",
        "research",
        "phase",
        "president",
        "olumiant",
        "baricitinib",
        "evercore",
        "leerink",
        "lead",
        "reporting",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}